DDAH2 and cancer: The expression of DDAH2 and systemic SDMA and DMA were, in turn, associated with circulating SCGFβ, a growth factor for primitive hematopoietic progenitor cells, which is overexpressed in cancer by circulating cancer cells [62] and drug-resistant cancer stem cells [63].